A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neck
- 1 May 2000
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 11 (5) , 535-540
- https://doi.org/10.1023/a:1008355413788
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neckCancer, 1998
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Docetaxel: an active drug for squamous cell carcinoma of the head and neck.Journal of Clinical Oncology, 1996
- Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neckAnnals of Oncology, 1994
- Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.Journal of Clinical Oncology, 1992
- A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neckBritish Journal of Cancer, 1990
- Evaluation of High-Dose Cisplatin and 5-FU Infusion as Initial Therapy in Advanced Head and Neck CancerAmerican Journal of Clinical Oncology, 1988
- A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neckCancer, 1985
- Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neckCancer, 1984
- A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancerCancer, 1981